Intellectual property rights
How can countries overcome US monopoly over Remdesivir?

After making America sick again, president Donald Trump is trying to compensate for his administration’s failure by buying up the entire stock of Remdesivir from Gilead for the next three months for the US, and leaving nothing for the rest of the world.

US declares vaccine war on the world

What prevents any country from making drugs and vaccines, once developed? Is it the threat of the US, or the belief that in the US-China vaccine war, they need to be on the US side?

World Health Assembly 2020 Mixed outcomes at the ‘COVID-19 World Health Assembly’

The 73rd World Health Assembly saw the US continue its attack on China and the World Health Organization. The WHA recognized immunization as a global public health good but failed to do the same for vaccines

Global north has forgotten that private sector wants ill-health

The increasing corporatisation of the health sector has meant that private interests not only play a huge role in determining policy, but also control licensing. This is a threat for countries like India.

How can we confront patent regimes in the fight against COVID-19?

Newsclick’s Prabir Purkayastha talks about issues around intellectual property rights in the time of the COVID-19 pandemic.

RCEP RCEP: As deadline looms, trade unions call out dangerous clauses

Negotiators representing 16 countries have been tasked with arriving at an agreement on the controversial Regional Comprehensive Economic Partnership by October 19 but trade unions say the deal has grave consequences

PepsiCo withdraws cases against nine farmers following global outrage

PepsiCo’s decision to sue the nine farmers to the tune of hundreds of thousands of dollars had led to a campaign to boycott its products in the country

US and China US and China close to a deal, but who won the trade war?

The Trump administration’s premature jubilation over the new trade deal should not be taken at face value, since the existing terms of trade are set to remain largely unchanged

Patent Opposition Filed For Johnson And Johnson’s TB Medicine

Nandita Venkatesan and her co-petitioner from South Africa, Phumeza Tisile, are challenging a further extension of the patent that Johnson & Johnson has applied for the salt form of the drug, bedaquline that could be of vital importance in treating drug-resistant TB

Activists gather in Bangkok to discuss countering RCEP

The deal is likely to deal a huge blow to the less developed countries in the Asia-Pacific region and benefit big corporations and the richer countries

Organizations oppose secretive negotiations around RCEP trade agreement

A report released on Friday says the public consultation around the deal has been extremely poor, while corporations have had undue influence on the discussions and the agenda

    × To Subscribe